Economic TimesLean R·
US stocks: Lilly shares rise on hopes that next-gen drug will extend lead in weight-loss market
Lilly presented full data from two retatrutide trials, one in treatment naive type 2 diabetes patients and another in patients with obesity, at the American Diabetes Association meeting in New Orleans.
Read at Economic Times →
